Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Clinical Epidemiology|April 16, 2019
Established search filters may miss studies when identifying randomized controlled trialsChris Cooper, Jo Varley-Campbell, Patrice Carter
BMC Medical Research Methodology|March 7, 2019
Evaluating the effectiveness, efficiency, cost and value of contacting study authors in a systematic review: a case study and worked exampleChris Cooper, Juan Talens Bou, Jo Varley-Campbell
BMC Medical Research Methodology|August 16, 2018
Defining the process to literature searching in systematic reviews: a literature review of guidance and supporting studiesChris Cooper, Andrew Booth, Jo Varley-Campbell, et al.
Sports Medicine (Auckland, N.Z.)|September 21, 2018
Sex-Specific Changes in Physical Performance Following Military Training: A Systematic ReviewJo Varley-Campbell, Chris Cooper, Daryl Wilkerson, et al.
Research Synthesis Methods|July 22, 2018
Revisiting the need for a literature search narrative: A brief methodological noteChris Cooper, Sarah Dawson, Jaime Peters, et al.
Sports Medicine - Open|December 3, 2020
Recurrent and Subsequent Injuries in Professional and Elite Sport: a Systematic ReviewCharlotte Leah Bitchell, Jo Varley-Campbell, Gemma Robinson, et al.
Sports Medicine (Auckland, N.Z.)|March 23, 2019
Effect of Immobilisation on Neuromuscular Function In Vivo in Humans: A Systematic ReviewMatthew Campbell, Jo Varley-Campbell, Jon Fulford, et al.
Diagnostic and Prognostic Research|December 9, 2020
Lung cancer screening by low-dose computed tomography: a cost-effectiveness analysis of alternative programmes in the UK using a newly developed natural history-based economic modelEdward Griffin, Chris Hyde, Linda Long, et al.
Sports Medicine (Auckland, N.Z.)|April 6, 2019
Correction to: Effect of Immobilisation on Neuromuscular Function In Vivo in Humans: A Systematic ReviewMatthew Campbell, Jo Varley-Campbell, Jon Fulford, et al.
Pharmacoeconomics|March 3, 2018
Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in EnglandIrina A Tikhonova, Nicola Huxley, Tristan Snowsill, et al.
Pageof 2